Genomic Insights / Industry Insights

WuXi NextCODE Appoints Accomplished Life Sciences Senior Executive Louis Yuan as China General Manager

Brings two decades of proven sales, marketing and team management expertise at Becton Dickinson, Pfizer and Sanofi to oversee the growth of WuXi NextCODE’s China business and operations

Louis Yuan18 January 2018 – WuXi NextCODE, the emerging global standard platform for genomic data, today announced the appointment of Louis Yuan as senior vice president and China General Manager. In this position he will lead the growth of all the company’s China businesses, sales and other operations based out of its Shanghai site.

“We are very pleased to begin 2018 by welcoming Louis onboard to spearhead the next phase in the expansion of our genomics platform and its commercialization in China,” said Hannes Smarason, CEO of WuXi NextCODE. “The accelerating growth across our platform – from our rare disease and consumer-focused tests to large-scale projects for pharma, research hospitals and government – requires leadership experience and a record of success across many fields. Louis has that track record across China, and we are very excited to have him apply his talents to drive our commercial growth strategy and to impact the lives of more patients and people across China and globally.”

“Genomics is revolutionizing every aspect of the life sciences and medicine, and WuXi NextCODE is the leading platform enabling the delivery of the benefits of the genome in China and around the world,” said Louis Yuan. “It is a pleasure and an honor to be joining this exceptional enterprise at such a transformational time. Throughout my career I have focused on helping to create products that make people better or keep them healthy, and on making sure that those products medicines reach the people they can benefit. Using the genome to do that is what WuXi NextCODE is all about and I am thrilled to get to work delivering on that vision.”

Louis Yuan joins WuXi NextCODE with a stellar record of commercial success, scaling and managing sales teams of more than 300 and achieving multiple triple-digit revenue ramps in his businesses. For the past six years he has served as senior business unit director for Becton Dickinson’s pharmaceutical systems franchise across Greater China. Prior to that he was senior director of sales within Pfizer’s vaccine business in China, where he launched blockbuster Prevenar. From 1998 to 2006 he served in a range of marketing and sales positions within Sanofi Pasteur. Mr Yuan began his life sciences career as research assistant of the Beijing AIDS Clinical Research Center at Ditan Hospital and received his master’s degree in medicine from the Chinese Academy of Preventive Medicine and Qingdao University.

About WuXi NextCODE

WuXi NextCODE is a fully integrated contract genomics organization (CGO) building the global standard platform for genomic data. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we serve the leading population genomics, precision medicine, diagnostics and wellness initiatives and enterprises using the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis, storage, interpretation, scalable analytics, and AI and deep learning – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same capabilities to advance a growing range of sequence-based tests and scans in China. Visit us on the web at wuxinextcode.com.

Contact:

Edward Farmer, PhD
efarmer@wuxinextcode.com
+1 781-775-6206

JiaWei Wang
jw_wang@wuxinextcode.com
+86 21 5046 5558